Fabrication of silver nanocomposite of azithromycin and tulsi against in vitro Pseudomonas inhibition
In most cases, azithromycin gets resistant to bacterial infections. To overcome this issue, the silver nanocomposite of azithromycin could be a better alternative against Pseudomonas and other Gram-negative precarious infections.
Authors
- Kiran Dobhal (ORCID: https://orcid.org/0000-0002-2797-9875)
- Vikash Jakhmola (ORCID: https://orcid.org/0000-0002-8108-006X)
- Jaya Rautela (ORCID: https://orcid.org/0000-0003-4794-6920)
- Naveen Chandra Joshi (ORCID: https://orcid.org/0000-0003-0095-9695)
Institutions
- Uttaranchal University (IN)
- Hindu College of Pharmacy (IN)
- Graphic Era University (IN)
Publication Details
- Journal
- Indian Journal of Pharmacology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/ijp.ijp_284_23
- Primary Topic
- Nanoparticles: synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00